Bibliography

Export 26 results:

Filters: Keyword is Prevalence [Clear All Filters]

2015

Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J, et al. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Vox sanguinis// // Vox Sang. 2015;108(2):113-22.

Aydinok Y, Porter J, Piga A, Elalfy M, El-Beshlawy A, Kilinc Y, et al. Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study. //Eur J Haematol. 2015.

Mezochow AK, Henry R, Blumberg EA, Kotton CN. Transfusion transmitted infections in solid organ transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// // Am J Transplant. 2015;15(2):547-54.

2014

Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet//Lancet. 2014;384(9956):1766-73.

Salvin HE, Pasricha S-, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion//Transfusion. 2014;54(10):2434-44.

2012

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. HTLV-1 in solid-organ transplantation: current challenges and future management strategies. Transplantation// Transplantation. 2012;94(11):1075-84.

Trottier H, Buteau C, Robitaille N, Duval M, Tucci M, Lacroix J, et al. Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children. Transfusion// Transfusion. 2012;52(12):2653-63.

2011

Owusu-Ofori AK, Parry CM, Bates I. Transfusion-transmitted syphilis in teaching hospital, Ghana. Emerging infectious diseases//Emerg Infect Dis. 2011;17(11):2080-2.

2009

Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15(10):5.

2008

Yin M, Bastacky S, Chandran U, Becich MJ, Dhir R. Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol. 2008;179(3):892-5; - discussion - 895.

2007

Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, et al. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant. 2007;7(12):2723-6.

2005

Robert PY, Adenis JP, Pleyer U. [How "safe" is corneal transplantation? A contribution on the risk of HSV-transmission due to corneal transplantation]. Klin Monbl Augenheilkd. 2005;222(11):870-3.

Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. Journal of Hepatology. 2005;42(6):813-9.

2004

Rehany U, Balut G, Lefler E, Rumelt S. The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. Cornea. 2004;23(7):649-54.

Zou S, Dodd RY, Stramer SL, Strong DM, Group T. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351(8):751-9.

2002

Passos EP, Silveira TR, Salazar CC, Facin AC, Souza CA, Guerin YL, et al. Hepatitis C virus infection and assisted reproduction. Hum Reprod. 2002;17(8):2085-8.

Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42(10):1293-301.

1999

Isaacson AH, Bhardwaj B, Qian K, Davis GL, Kato T, Mizokami M, et al. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat. 1999;6(2):151-60.

Hogan RN, Brown P, Heck E, Cavanagh HD. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18(1):2-11.

1998

Karayiannis P, Brind AM, Pickering J, Mathew J, Burt AD, Hess G, et al. Hepatitis G virus does not cause significant liver disease after liver transplantation. J Viral Hepat. 1998;5(1):35-42.

Pillonel J, Saura C, Courouce AM. [Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996]. TransfusClinBiol. 1998;5(5):05.

Pillonel J, Saura C, Couroucé AM. [Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996]. Transfus Clin Biol. 1998;5(5):305-12.

1997

Murthy BV, Muerhoff AS, Desai SM, Lund J, Schmid CH, Levey AS, et al. GB hepatitis agent in cadaver organ donors and their recipients. Transplantation. 1997;63(3):346-51.

1993

Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, et al. Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors. TransplantProc. 1993;25(1 Pt 2):8.

1992

Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, et al. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology. 1992;103(1).

Pages